During the past decade, Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie" #1 collaborator was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator and "Spectrum Pharmaceuticals, Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie" are "CD20+ Aggressive B-Cell Lymphoma" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie" in a lesser frequency.

Most popular intervention types in "Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (1 trials), "Conventional Vincristine" (1 trials), "Dexamethasone" (1 trials), "Isatuximab" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".